From: Factors that influence the levels of cerebrospinal fluid biomarkers in memory clinic patients
Variables | Unadjusted standardized beta | P | R square | Adjusted standardized beta | P |
---|---|---|---|---|---|
Patients with MMSE sum score ≥ 25, N = 134 | |||||
Diagnoses (AD/aMCI = 2, others = 1) | 0.42 | <0.001 | 0.17 | 0.36 | <0.001 |
Age | 0.11 | 0.2 | 0.005 | ||
Sex (1 = women, 2 = men) | −0.18 | 0.04 | 0.03 | ||
ApoE ε4 genotype (neg = 1, pos = 2) | 0.23 | 0.007 | 0.05 | 0.17 | 0.03 |
Amyloid β | −0.35 | <0.001 | 0.11 | ||
MMSE | −0.33 | <0.001 | 0.1 | −0.25 | 0.002 |
R square, adjusted | 0.26 | ||||
Patients with MMSE sum score < 25, N = 119 | |||||
Age | 0.12 | 0.18 | 0.007 | ||
Sex (1 = women, 2 = men) | 0.006 | 0.95 | −0.009 | ||
ApoE ε4 genotype (neg = 1, pos = 2) | 0.17 | 0.07 | 0.02 | ||
Amyloid β | −024 | 0.01 | 0.05 | −0.24 | 0.01 |
MMSE | −017 | 0.06 | 0.02 | ||
R square, adjusted | 0.05 |